Davenport & CO LLC Novo Nordisk A S Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

A detailed history of Davenport & CO LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Davenport & CO LLC holds 603,441 shares of NVO stock, worth $82.7 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

603,441

Previous 604,472 0.17%

Holding current value

$82.7 Million

Previous $77.6 Million 10.98%

% of portfolio

0.54%

Previous 0.49%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$122.71 - $146.91 $126,514 - $151,464	-1,031 Reduced 0.17%	603,441 $86.1 Million
Q1 2024 May 03, 2024	SELL	$102.11 - $135.92 $30,837 - $41,047	-302 Reduced 0.05%	604,472 $77.6 Million
Q4 2023 Jan 23, 2024	BUY	$87.78 - $105.45 $168,274 - $202,147	1,917 Added 0.32%	604,774 $62.6 Million
Q3 2023 Oct 17, 2023	BUY	$90.94 - $199.54 $27.5 Million - $60.4 Million	302,626 Added 100.8%	602,857 $54.8 Million
Q2 2023 Jul 20, 2023	SELL	$155.98 - $172.65 $15.1 Million - $16.7 Million	-96,748 Reduced 24.37%	300,231 $48.6 Million
Q1 2023 Apr 27, 2023	SELL	$132.34 - $159.14 $630,732 - $758,461	-4,766 Reduced 1.19%	396,979 $63.2 Million
Q4 2022 Jan 20, 2023	BUY	$102.55 - $135.33 $40.1 Million - $53 Million	391,397 Added 3782.34%	401,745 $0
Q3 2022 Oct 11, 2022	BUY	$95.28 - $116.93 $415,706 - $510,165	4,363 Added 72.9%	10,348 $1.03 Million
Q2 2022 Jul 18, 2022	BUY	$103.24 - $121.81 $32,520 - $38,370	315 Added 5.56%	5,985 $667,000
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $25,137 - $30,385	-270 Reduced 4.55%	5,670 $630,000
Q4 2021 Feb 10, 2022	SELL	$95.88 - $117.08 $45,543 - $55,613	-475 Reduced 7.4%	5,940 $665,000
Q3 2021 Oct 14, 2021	BUY	$84.42 - $106.62 $91,848 - $116,002	1,088 Added 20.42%	6,415 $616,000
Q2 2021 Jul 28, 2021	BUY	$67.66 - $84.76 $2,841 - $3,559	42 Added 0.79%	5,327 $446,000
Q4 2020 Jan 13, 2021	SELL	$63.89 - $73.8 $7,666 - $8,856	-120 Reduced 2.22%	5,285 $369,000
Q4 2019 Jan 22, 2020	BUY	$49.86 - $58.26 $6,431 - $7,515	129 Added 2.45%	5,405 $313,000
Q3 2019 Oct 16, 2019	BUY	$47.54 - $53.43 $4,563 - $5,129	96 Added 1.85%	5,276 $269,000
Q2 2019 Jul 10, 2019	SELL	$46.79 - $52.47 $23,395 - $26,235	-500 Reduced 8.8%	5,180 $264,000
Q1 2019 Apr 17, 2019	SELL	$46.36 - $52.63 $8,113 - $9,210	-175 Reduced 2.99%	5,680 $297,000
Q4 2018 Jan 28, 2019	BUY	$41.54 - $47.25 $13,292 - $15,120	320 Added 5.78%	5,855 $270,000
Q3 2018 Oct 11, 2018	SELL	$46.76 - $51.24 $9,352 - $10,248	-200 Reduced 3.49%	5,535 $261,000
Q1 2018 Apr 04, 2018	SELL	$48.49 - $58.14 $18,183 - $21,802	-375 Reduced 6.14%	5,735 $282 Million
Q4 2017 Jan 17, 2018	SELL	$47.53 - $53.73 $54,659 - $61,789	-1,150 Reduced 15.84%	6,110 $328 Million
Q3 2017 Oct 12, 2017	BUY	$41.15 - $49.22 $298,749 - $357,337	7,260	7,260 $350 Million

Others Institutions Holding NVO

# of Institutions

1,990

Shares Held

318M

Call Options Held

5.23M

Put Options Held

4.97M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $309B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account